Drug Type Enzyme |
Synonyms- |
Target |
Mechanism ASB modulators(arylsulfatase B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization M6P TherapeuticsStartup |
Active Organization M6P TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucopolysaccharidosis VI | Preclinical | US | M6P TherapeuticsStartup | 01 Nov 2024 |